198 results on '"Terkivatan, T."'
Search Results
2. Preoperative dietary intake of low-dose sulforaphane induces no clinically significant effect in living donor kidney transplantation
- Author
-
Oudmaijer, C.A.J., de Bruin, R.W.F., Ooms, L.S.S., Selten, J.W., van Straalen, E., Ambagtsheer, G., Terkivatan, T., and IJzermans, J.N.M.
- Published
- 2024
- Full Text
- View/download PDF
3. Preoperative dietary intake of low-dose sulforaphane induces no clinically significant effect in living donor kidney transplantation
- Author
-
Oudmaijer, C. A.J., de Bruin, R. W.F., Ooms, L. S.S., Selten, J. W., van Straalen, E., Ambagtsheer, G., Terkivatan, T., IJzermans, J. N.M., Oudmaijer, C. A.J., de Bruin, R. W.F., Ooms, L. S.S., Selten, J. W., van Straalen, E., Ambagtsheer, G., Terkivatan, T., and IJzermans, J. N.M.
- Abstract
Introduction: Sulforaphane (SFN) has anti-inflammatory properties, and is found in broccoli sprouts. Studies suggest that it protects against disease due to its anti-inflammatory activity. The impact of SFN on healthy people undergoing a surgical procedure has not been investigated. Objective: To explore the effect of SFN in living kidney donors on the postoperative inflammatory response and recovery. Methods: We performed a double-blind randomised controlled trial where donors followed a SFN-enriched (8 mg) preoperative diet. Results:A total of 42 donors were included, there were no significant differences at baseline. Postoperative inflammatory response was consistent among both arms and subjective recovery showed no significant difference. Findings regarding postoperative kidney function suggest no consistently significant impact. Discussion: A well-defined SFN-enriched diet did not have anti-inflammatory or a clinically relevant effect on the outcome. Due to the complexity of dietary modification of the inflammatory response, additional research is needed.
- Published
- 2024
4. Kidney Retransplantation in the Ipsilateral Iliac Fossa: A Surgical Challenge
- Author
-
Ooms, L.S.S., Roodnat, J.I., Dor, F.J.M.F., Tran, T.C.K., Kimenai, H.J.A.N., Ijzermans, J.N.M., and Terkivatan, T.
- Published
- 2015
- Full Text
- View/download PDF
5. 16 Levertumoren
- Author
-
Terkivatan, T., Verhoef, C., IJzermans, J.N.M., de Man, R. A., Janssen, H.L.A., editor, Drenth, J.P.H., editor, and van Hoek, B., editor
- Published
- 2009
- Full Text
- View/download PDF
6. Safety and Efficacy of Third Kidney Transplantation in Ipsilateral Iliac Fossa
- Author
-
Domagala, Piotr, van den Berg, T, Tran, K., Terkivatan, T., Kimenai, H., IJzermans, J., Pol, R., and Minnee, R.C.
- Published
- 2018
- Full Text
- View/download PDF
7. Living Kidney Donors: Impact of Age on Long-Term Safety
- Author
-
Dols, L.F.C., Kok, N.F.M., Roodnat, J.I., Tran, T.C.K., Terkivatan, T., Zuidema, W.C., Weimar, W., and IJzermans, J.N.M.
- Published
- 2011
- Full Text
- View/download PDF
8. Implementation and Outcomes of Robotic Liver Surgery in the Netherlands (LAELIVE-Robot): A Nationwide Retrospective Cohort
- Author
-
Gorgec, B., primary, Zwart, M., additional, Nota, C.L., additional, Bosscha, K., additional, Mieog, S., additional, Terkivatan, T., additional, IJzermans, J.N.M., additional, Te Riele, W., additional, De Boer, M.T., additional, Buis, C.I., additional, Gerhards, M.F., additional, Marsman, H.A., additional, Liem, M.S., additional, Lips, D.J., additional, Rinkes, I., additional, Molenaar, Q.I., additional, Besselink, M.G., additional, Swijnenburg, R.J., additional, and Hagendoorn, J., additional
- Published
- 2022
- Full Text
- View/download PDF
9. Is Current Perioperative Practice in Hepatic Surgery Based on Enhanced Recovery After Surgery (ERAS) Principles?
- Author
-
Wong-Lun-Hing, E. M., van Dam, R. M., Heijnen, L. A., Busch, O. R. C., Terkivatan, T., van Hillegersberg, R., Slooter, G. D., Klaase, J., de Wilt, J. H. W., Bosscha, K., Neumann, U. P., Topal, B., Aldrighetti, L. A., and Dejong, C. H. C.
- Published
- 2014
- Full Text
- View/download PDF
10. Comparing practice and outcome of laparoscopic liver resection between high-volume expert centres and nationwide low-to-medium volume centres
- Author
-
Görgec, B, primary, Fichtinger, R S, additional, Ratti, F, additional, Aghayan, D, additional, Van der Poel, M J, additional, Al-Jarrah, R, additional, Armstrong, T, additional, Cipriani, F, additional, Fretland, Å A, additional, Suhool, A, additional, Bemelmans, M, additional, Bosscha, K, additional, Braat, A E, additional, De Boer, M T, additional, Dejong, C H C, additional, Doornebosch, P G, additional, Draaisma, W A, additional, Gerhards, M F, additional, Gobardhan, P D, additional, Hagendoorn, J, additional, Kazemier, G, additional, Klaase, J, additional, Leclercq, W K G, additional, Liem, M S, additional, Lips, D J, additional, Marsman, H A, additional, Mieog, J S D, additional, Molenaar, Q I, additional, Nieuwenhuijs, V B, additional, Nota, C L, additional, Patijn, G A, additional, Rijken, A M, additional, Slooter, G D, additional, Stommel, M W J, additional, Swijnenburg, R J, additional, Tanis, P J, additional, Te Riele, W W, additional, Terkivatan, T, additional, Van den Tol, P M P, additional, Van den Boezem, P B, additional, Van der Hoeven, J A, additional, Vermaas, M, additional, Edwin, B, additional, Aldrighetti, L A, additional, Van Dam, R M, additional, Abu Hilal, M, additional, and Besselink, M G, additional
- Published
- 2021
- Full Text
- View/download PDF
11. Comparing practice and outcome of laparoscopic liver resection between high-volume expert centres and nationwide low-to-medium volume centres
- Author
-
Görgec, B., Fichtinger, R.S., Ratti, F., Aghayan, D., Poel, M.J.C.M. van der, Al-Jarrah, R., Armstrong, T., Cipriani, F., Fretland, A.A., Suhool, A., Bemelmans, M., Bosscha, K., Braat, A.E., Boer, M.T. De, Dejong, C.H.C., Doornebosch, P.G., Draaisma, W.A., Gerhards, M.F., Gobardhan, P.D., Hagendoorn, J., Kazemier, G., Klaase, J., Leclercq, W.K., Liem, M.S., Lips, D.J., Marsman, H.A., Mieog, J.Sven D., Molenaar, Q.I., Nieuwenhuijs, V.B., Nota, C.L., Patijn, G.A., Rijken, A.M., Slooter, G.D., Stommel, M.W.J., Swijnenburg, R.J., Tanis, P.J., Riele, W.W. ter, Terkivatan, T., Tol, P.M.P. van den, Boezem, P.B. van den, Hoeven, Jacobus van der, Vermaas, M., Edwin, B., Aldrighetti, L.A., Dam, R.M. van, Hilal, M. Abu, Besselink, M.G.H., Görgec, B., Fichtinger, R.S., Ratti, F., Aghayan, D., Poel, M.J.C.M. van der, Al-Jarrah, R., Armstrong, T., Cipriani, F., Fretland, A.A., Suhool, A., Bemelmans, M., Bosscha, K., Braat, A.E., Boer, M.T. De, Dejong, C.H.C., Doornebosch, P.G., Draaisma, W.A., Gerhards, M.F., Gobardhan, P.D., Hagendoorn, J., Kazemier, G., Klaase, J., Leclercq, W.K., Liem, M.S., Lips, D.J., Marsman, H.A., Mieog, J.Sven D., Molenaar, Q.I., Nieuwenhuijs, V.B., Nota, C.L., Patijn, G.A., Rijken, A.M., Slooter, G.D., Stommel, M.W.J., Swijnenburg, R.J., Tanis, P.J., Riele, W.W. ter, Terkivatan, T., Tol, P.M.P. van den, Boezem, P.B. van den, Hoeven, Jacobus van der, Vermaas, M., Edwin, B., Aldrighetti, L.A., Dam, R.M. van, Hilal, M. Abu, and Besselink, M.G.H.
- Abstract
Contains fulltext : 238990.pdf (Publisher’s version ) (Closed access), BACKGROUND: Based on excellent outcomes from high-volume centres, laparoscopic liver resection is increasingly being adopted into nationwide practice which typically includes low-medium volume centres. It is unknown how the use and outcome of laparoscopic liver resection compare between high-volume centres and low-medium volume centres. This study aimed to compare use and outcome of laparoscopic liver resection in three leading European high-volume centres and nationwide practice in the Netherlands. METHOD: An international, retrospective multicentre cohort study including data from three European high-volume centres (Oslo, Southampton and Milan) and all 20 centres in the Netherlands performing laparoscopic liver resection (low-medium volume practice) from January 2011 to December 2016. A high-volume centre is defined as a centre performing >50 laparoscopic liver resections per year. Patients were retrospectively stratified into low, moderate- and high-risk Southampton difficulty score groups. RESULTS: A total of 2425 patients were included (1540 high-volume; 885 low-medium volume). The median annual proportion of laparoscopic liver resection was 42.9 per cent in high-volume centres and 7.2 per cent in low-medium volume centres. Patients in the high-volume centres had a lower conversion rate (7.4 versus 13.1 per cent; P < 0.001) with less intraoperative incidents (9.3 versus 14.6 per cent; P = 0.002) as compared to low-medium volume centres. Whereas postoperative morbidity and mortality rates were similar in the two groups, a lower reintervention rate (5.1 versus 7.2 per cent; P = 0.034) and a shorter postoperative hospital stay (3 versus 5 days; P < 0.001) were observed in the high-volume centres as compared to the low-medium volume centres. In each Southampton difficulty score group, the conversion rate was lower and hospital stay shorter in high-volume centres. The rate of intraoperative incidents did not differ in the low-risk group, whilst in the moderate-risk
- Published
- 2021
12. Learning curves of minimally invasive donor nephrectomy in a high-volume center: A cohort study of 1895 consecutive living donors
- Author
-
Takagi, K. (Kosei), Kimenai, H.J.A.N. (Hendrikus), Terkivatan, T. (Türkan), Tran, T.C.K. (Khe), Ijzermans, J.N.M. (Jan N.M.), Minnee, R.C., Takagi, K. (Kosei), Kimenai, H.J.A.N. (Hendrikus), Terkivatan, T. (Türkan), Tran, T.C.K. (Khe), Ijzermans, J.N.M. (Jan N.M.), and Minnee, R.C.
- Abstract
Background: Few studies have investigated the learning curves of minimally invasive donor nephrectomy (MIDN) using the cumulative sum (CUSUM) analysis. In addition, no study has compared the learning curves of the different surgical MIDN techniques in one cohort study using the CUSUM
- Published
- 2021
- Full Text
- View/download PDF
13. Comparing practice and outcome of laparoscopic liver resection between high-volume expert centres and nationwide low-to-medium volume centres
- Author
-
Zorgeenheid Vaatchirurgie Zorg, MS CGO, Cancer, Görgec, B., Fichtinger, R. S., Ratti, F., Aghayan, D., Van der Poel, M. J., Al-Jarrah, R., Armstrong, T., Cipriani, F., Fretland, ÅA, Suhool, A., Bemelmans, M., Bosscha, K., Braat, A. E., De Boer, M. T., Dejong, C. H.C., Doornebosch, P. G., Draaisma, W. A., Gerhards, M. F., Gobardhan, P. D., Hagendoorn, J., Kazemier, G., Klaase, J., Leclercq, W. K.G., Liem, M. S., Lips, D. J., Marsman, H. A., Mieog, J. S.D., Molenaar, Q. I., Nieuwenhuijs, V. B., Nota, C. L., Patijn, G. A., Rijken, A. M., Slooter, G. D., Stommel, M. W.J., Swijnenburg, R. J., Tanis, P. J., Te Riele, W. W., Terkivatan, T., Van den Tol, P. M.P., Van den Boezem, P. B., Van der Hoeven, J. A., Vermaas, M., Edwin, B., Aldrighetti, L. A., Van Dam, R. M., Abu Hilal, M., Besselink, M. G., Zorgeenheid Vaatchirurgie Zorg, MS CGO, Cancer, Görgec, B., Fichtinger, R. S., Ratti, F., Aghayan, D., Van der Poel, M. J., Al-Jarrah, R., Armstrong, T., Cipriani, F., Fretland, ÅA, Suhool, A., Bemelmans, M., Bosscha, K., Braat, A. E., De Boer, M. T., Dejong, C. H.C., Doornebosch, P. G., Draaisma, W. A., Gerhards, M. F., Gobardhan, P. D., Hagendoorn, J., Kazemier, G., Klaase, J., Leclercq, W. K.G., Liem, M. S., Lips, D. J., Marsman, H. A., Mieog, J. S.D., Molenaar, Q. I., Nieuwenhuijs, V. B., Nota, C. L., Patijn, G. A., Rijken, A. M., Slooter, G. D., Stommel, M. W.J., Swijnenburg, R. J., Tanis, P. J., Te Riele, W. W., Terkivatan, T., Van den Tol, P. M.P., Van den Boezem, P. B., Van der Hoeven, J. A., Vermaas, M., Edwin, B., Aldrighetti, L. A., Van Dam, R. M., Abu Hilal, M., and Besselink, M. G.
- Published
- 2021
14. Abdominal wall paresis as a complication of laparoscopic surgery
- Author
-
van Ramshorst, G. H., Kleinrensink, G.-J., Hermans, J. J., Terkivatan, T., and Lange, J. F.
- Published
- 2009
- Full Text
- View/download PDF
15. Growth of hepatocellular adenoma during pregnancy: A prospective study
- Author
-
Gaspersz, M.P. (Marcia), Klompenhouwer, A.J. (Anne Julia), Bröker, M.E.E. (Mirelle), Thomeer, M.G.J. (Maarten Gerardus Josephus), Aalten, S.M. (Susanna) van, Steegers, E.A.P. (Eric), Terkivatan, T. (Türkan), de Koning, H. (Harry), Man, R.A. (Robert) de, IJzermans, J.N.M. (Jan), Gaspersz, M.P. (Marcia), Klompenhouwer, A.J. (Anne Julia), Bröker, M.E.E. (Mirelle), Thomeer, M.G.J. (Maarten Gerardus Josephus), Aalten, S.M. (Susanna) van, Steegers, E.A.P. (Eric), Terkivatan, T. (Türkan), de Koning, H. (Harry), Man, R.A. (Robert) de, and IJzermans, J.N.M. (Jan)
- Abstract
Background & Aims: The presence of hepatocellular adenoma (HCA) in pregnant women requires special consideration, as it has been reported to carry the risk of growth and clinically significant haemorrhage. In this prospective study we assessed aspects of growth of HCA <5 cm during pregnancy. Methods: This was a multicentre prospective cohort study in pregnant women with suspected HCA <5 cm on imaging. Definitive HCA diagnosis was established by MRI with hepatobiliary contrast agents (LCE-MRI), preferably before pregnancy. If at study inclusion a definitive diagnosis was lacking, LCE-MRI was performed after giving birth. Growth of the adenoma (defined as an increase of >20%) was closely monitored with ultrasound examinations throughout pregnancy. Results: Of the 66 women included, 18 were excluded from analysis because postpartum LCE-MRI did not confirm the diagnosis of HCA and showed the lesion to be focal nodular hyperplasia. The remaining 48 women, with an HCA confirmed by LCE-MRI, were followed during 51 pregnancies. Median age was 30 years (IQR 27–33) and median body mass index 31.9 kg/m2 (IQR 26.3–36.6). Growth of HCA was seen in 13 of the pregnancies (25.5%); the median increase was 14 mm (IQR 8–19). One woman whose HCA grew to >70 mm successfully underwent transarterial embolization at week 26 of pregnancy to prevent further growth. The other 50 pregnancies proceeded without complications. Conclusion: This study suggests that an HCA <5 cm confers minimal risk to a pregnant woman and none to her child. HCA increased in size during a quarter of pregnancies, so we recommend close monitoring with ultrasound examinations, enabling intervention if needed. In light of the large proportion of misdiagnosed HCA, LCE-MRI should be performed to prevent unnecessary anxiety in women with a benign liver lesion. Lay summary: The presence of hepatocellular adenoma in pregnant women requires special consideration, as it carries the risk of growth and haemorrhage. In this study
- Published
- 2020
- Full Text
- View/download PDF
16. Stenting the ureteroneocystostomy reduces urological complications in kidney transplantation: a noninferiority randomized controlled trial, SPLINT trial
- Author
-
Ooms, L.S.S. (Liselotte), Minnee, R.C., Dor, F.J.M.F. (Frank), Kimenai, D.J.A.N. (Diederik J. A. N.), Tran, K.C.K. (Khe C. K.), Hartog, H. (Hermien), Wetering, J. (Jacqueline) van de, Willemsen, S.P. (Sten), IJzermans, J.N.M. (Jan), Terkivatan, T. (Türkan), Ooms, L.S.S. (Liselotte), Minnee, R.C., Dor, F.J.M.F. (Frank), Kimenai, D.J.A.N. (Diederik J. A. N.), Tran, K.C.K. (Khe C. K.), Hartog, H. (Hermien), Wetering, J. (Jacqueline) van de, Willemsen, S.P. (Sten), IJzermans, J.N.M. (Jan), and Terkivatan, T. (Türkan)
- Abstract
The role of ureteral stents in living-donor kidney transplantation remains uncertain. In this randomized controlled trial (SPLINT), we compared urological complications in living-donor kidney transplantations performed with or without stents. We included 200 consecutive patients that received living-donor kidney transplantations at the Erasmus MC, University Medical Center, Rotterdam. Patients (124 males, 76 females, mean age 54 ± 13) were randomized for suprapubic externalized single J stents (N = 100) or no stent (N = 100). The primary outcome was the probability of a percutaneous nephrostomy insertion (PCN) during a 12-month follow-up. To assess whether no stenting is noninferior to stenting, we allowed the probability of a PCN to increase by at most 5% (this is the noninferiority margin). Baseline characteristics were comparable between groups. In the no-stent group, there were more PCN insertions, 14% (95% CI 4.3–23.7%); urinary leakages, 12% (95% CI 5.4–21.3%); and surgical re-interventions because of urological complications, 8% (95% CI 1.5–14.5%). The stent group had more hematuria, 26% (95% CI 13.1–38.9%); and graft rejections, 15% (95% CI 2.7–27.3%). Patients in both groups had similar mean GFRs at several time points. Besides a better Euro-Qol-5D in the no-stent group at 2 and 6 weeks postoperative, similar quality of life was reported based on SF-36 and Euro-Qol-5D scores. In this trial, noninferiority has not been demonstrated for no-stent placement in relation to the number urological complications.
- Published
- 2020
- Full Text
- View/download PDF
17. A novel difficulty grading system for laparoscopic living donor nephrectomy
- Author
-
Takagi, K. (Kosei), Kimenai, H.J.A.N. (Hendrikus), Terkivatan, T. (Türkan), Tran, T.C.K. (Khe), IJzermans, J.N.M. (Jan), Minnee, R.C., Takagi, K. (Kosei), Kimenai, H.J.A.N. (Hendrikus), Terkivatan, T. (Türkan), Tran, T.C.K. (Khe), IJzermans, J.N.M. (Jan), and Minnee, R.C.
- Abstract
BACKGROUND: Several difficulty grading systems have been developed as a useful tool for selecting patients and training surgeons in laparoscopic procedures. However, there is little information on predicting the difficulty of laparoscopic donor nephrectomy (LDN). The aim of this study was to develop a grading system to predict the difficulty of LDN. METHODS: Data of 1741 living donors, who underwent pure or hand-assisted LDN between 1994 and 2018 were analyzed. Multivariable analyses were performed to identify factors associated with prolonged operative time, defined as a difficulty index with 0 to 8. The difficulty of LDN was classified into three levels based on the difficulty index. RESULTS: Multivariable analyses identified that male (odds ratio [OR] 1.69, 95% CI 1.37-2.09, P < 0.001), BMI > 28 (OR 1.36, 95% CI 1.08-1.72, P = 0.009), pure LDN (OR 1.99, 95% CI 1.53-2.60, P < 0.001), multiple renal arteries (OR 2.38, 95% CI 1.83-3.10, P < 0.001) and multiple renal veins (OR 2.18, 95% CI 1.52-3.16, P < 0.001) were independent risk factors influencing prol
- Published
- 2020
- Full Text
- View/download PDF
18. Learning curve of kidney transplantation in a high-volume center: A Cohort study of 1466 consecutive recipients
- Author
-
Takagi, K. (Kosei), Outmani, L. (Loubna), Kimenai, H.J.A.N. (Hendrikus), Terkivatan, T. (Türkan), Tran, T.C.K. (Khe), IJzermans, J.N.M. (Jan), Minnee, R.C., Takagi, K. (Kosei), Outmani, L. (Loubna), Kimenai, H.J.A.N. (Hendrikus), Terkivatan, T. (Türkan), Tran, T.C.K. (Khe), IJzermans, J.N.M. (Jan), and Minnee, R.C.
- Abstract
Background: The purpose of this study was to evaluate surgical outcomes of kidney transplantation (KTX) based on surgeon volume and surgeon experience, and to develop the learning curve model for KTX using the cumulative sum (CUSUM) analysis. Methods: A retrospective review of 1466 consecutive recipients who underwent KTX between 2010 and 2017 was conducted. In total, 51 surgeons, including certified transplant surgeons, transplant fellows and surgical residents were involved in these procedures using a standardized protocol. Outcomes were compared based on surgeon volume (low [1–30] versus high [31≥] volume) and surgeon's type (consultant surgeons, fellows or residents). Results: Operative time (129 versus 135 min, P < 0.001) and warm ischemia time (20.9 versus 24.2 min, P < 0.001) were significantly shorter in the high-volume group, however postoperative outcomes were equal in both groups. The CUSUM analysis revealed that approximately 30 procedures were necessary to improve surgical skills. In addition, no effect of surgeon's type including consultant surgeons, fellows and residents on postoperative outcomes was found. Conclusions: Surgical training in KTX using a standardize protocol can be accomplished with a steep learning curve without compromising perioperative outcomes under the careful selection of surgeons and procedures.
- Published
- 2020
- Full Text
- View/download PDF
19. Comparing Practice and Outcome of Laparoscopic Liver Resection Between High-volume Expert Centres and Nationwide Low-medium Volume Centres
- Author
-
Görgec, B., primary, Fichtinger, R., additional, Ratti, F., additional, Aghayan, D., additional, van der Poel, M., additional, Al-Jarrah, R., additional, Armstrong, T., additional, Cipriani, F., additional, Fretland, Å., additional, Suhool, A., additional, Bemelmans, M., additional, Bosscha, K., additional, Braat, A., additional, de Boer, M., additional, Dejong, C., additional, Doornebosch, P., additional, Draaisma, W., additional, Gerhards, M., additional, Gobardhan, P., additional, Hagendoorn, J., additional, Kazemier, G., additional, Klaase, J., additional, Leclerq, W., additional, Liem, M., additional, Lips, D., additional, Marsman, H., additional, Mieog, J., additional, Molenaar, Q., additional, Nieuwenhuijs, V., additional, Nota, C., additional, Patijn, G., additional, Rijken, A., additional, Slooter, G., additional, Stommel, M., additional, Swijnenburg, R., additional, Tanis, P., additional, Riele, W. Te, additional, Terkivatan, T., additional, van den Tol, P., additional, van den Boezem, P., additional, van der Hoeven, J., additional, Vermaas, M., additional, Edwin, B., additional, Aldrighetti, L., additional, van Dam, R., additional, Hilal, M. Abu, additional, and Besselink, M., additional
- Published
- 2021
- Full Text
- View/download PDF
20. Systematic review of haemorrhage and rupture of hepatocellular adenomas
- Author
-
van Aalten, S. M., de Man, R. A., IJzermans, J. N. M., and Terkivatan, T.
- Published
- 2012
- Full Text
- View/download PDF
21. Diagnosis and Treatment of Hepatocellular Adenoma in the Netherlands: Similarities and Differences
- Author
-
van Aalten, S. M., Terkivatan, T., de Man, R. A., van der Windt, D. J., Kok, N. F.M., Dwarkasing, R., and IJzermans, J. N.M.
- Published
- 2010
- Full Text
- View/download PDF
22. The Place of the Posterior Surgical Approach for Lesions of the Rectum
- Author
-
Terkivatan, T., den Hoed, P. T., Lange, J. F.M., Koot, V. C.M., van Goch, J. J., and Veen, H. F.
- Published
- 2005
- Full Text
- View/download PDF
23. Size of lesion is not a criterion for resection during management of giant liver haemangioma
- Author
-
Terkivatan, T., Vrijland, W. W., den Hoed, P. T., de Man, R. A., Hussain, S. M., Tilanus, H. W., and IJzermans, J. N. M.
- Published
- 2002
24. Treatment of ruptured hepatocellular adenoma
- Author
-
Terkivatan, T, de Wilt, J H. W, de Man, R A, van Rijn, R R, Tilanus, H W, and IJzermans, J N. M
- Published
- 2001
25. Management of hepatocellular adenoma during pregnancy
- Author
-
Terkivatan, T., de Wilt, J. H. W., de Man, R. A., and Ijzermans, J. N. M.
- Published
- 2000
26. Development of an International Standard Set of Value-Based Outcome Measures for Patients With Chronic Kidney Disease
- Author
-
Verberne, W.R. (Wouter R.), Das-Gupta, Z. (Zofia), Allegretti, A.S. (Andrew S.), Bart, H.A.J. (Hans A.J.), Biesen, W. (Wim) van, García-García, G. (Guillermo), Gibbons, E. (Elizabeth), Parra, E. (Eduardo), Hemmelder, M.H. (Marc), Jager, K.J. (Kitty), Ketteler, M. (Markus), Roberts, C. (Charlotte), Al Rohani, M. (Muhamed), Salt, M.J. (Matthew J.), Stopper, A. (Andrea), Terkivatan, T. (Türkan), Tuttle, K.R. (Katherine R.), Yang, C.-W. (Chih-Wei), Wheeler, D.C. (David C.), Bos, W.J.W. (Willem Jan), Verberne, W.R. (Wouter R.), Das-Gupta, Z. (Zofia), Allegretti, A.S. (Andrew S.), Bart, H.A.J. (Hans A.J.), Biesen, W. (Wim) van, García-García, G. (Guillermo), Gibbons, E. (Elizabeth), Parra, E. (Eduardo), Hemmelder, M.H. (Marc), Jager, K.J. (Kitty), Ketteler, M. (Markus), Roberts, C. (Charlotte), Al Rohani, M. (Muhamed), Salt, M.J. (Matthew J.), Stopper, A. (Andrea), Terkivatan, T. (Türkan), Tuttle, K.R. (Katherine R.), Yang, C.-W. (Chih-Wei), Wheeler, D.C. (David C.), and Bos, W.J.W. (Willem Jan)
- Abstract
Value-based health care is increasingly promoted as a strategy for improving care quality by benchmarking outcomes that matter to patients relative to the cost of obtaining those outcomes. To support the shift toward value-based health care in chronic kidney disease (CKD), the International Consortium for Health Outcomes Measurement (ICHOM) assembled an international working group of health professionals and patient representatives to develop a standardized minimum set of patient-centered outcomes targeted for clinical use. The considered outcomes and patient-reported outcome measures were generated from systematic literature reviews. Feedback was sought from patients and health professionals. Patients with very high-risk CKD (stages G3a/A3 and G3b/A2-G5, including dialysis, kidney transplantation, and conservative care) were selected as the target population. Using an online modified Delphi process, outcomes important to all patients were selected, such as survival and hospitalization, and to treatment-specific subgroups, such as vascular access survival and kidney allograft survival. Patient-reported outcome measures were included to capture domains of health-related quality of life, which were rated as the most important outcomes by patients. Demographic and clinical variables were identified to be used as case-mix adjusters. Use of these consensus recommendations could enable institutions to monitor, compare, and improve the quality of their CKD care.
- Published
- 2018
- Full Text
- View/download PDF
27. Antegrade balloon dilatation as a treatment option for posttransplant ureteral strictures: Case series of 50 patients
- Author
-
Ooms, L.S.S. (Liselotte), Moelker, A. (Adriaan), Roodnat, J.I. (Joke), IJzermans, J.N.M. (Jan), Idu, M.M. (Mirza), Terkivatan, T. (Türkan), Ooms, L.S.S. (Liselotte), Moelker, A. (Adriaan), Roodnat, J.I. (Joke), IJzermans, J.N.M. (Jan), Idu, M.M. (Mirza), and Terkivatan, T. (Türkan)
- Abstract
Objectives: The aim of this study was to investigate the effects of antegrade balloon dilatation on ureteral strictures that developed after kidney transplant. Materials and Methods: The hospital databases of the Erasmus Medical Center (Rotterdam, The Netherlands) and the Academic Medical Center (Amsterdam, The Netherlands) were retrospectively screened for patients who underwent balloon dilatation after kidney transplant. Balloon dilatation was technically successful whenever it was able to pass the strictured segment with the guidewire followed by balloon inflation; the procedure was clinically successful if no further interventions (for example, surgical revision of the ureteroneocystostomy or prolonged double J placement) were necessary. Results: Fifty patients (2.4%) of 2075 kidney transplant recipients underwent antegrade balloon dilatation because of urinary outflow obstruction. Median time between transplant and balloon dilatation was 3 months (range, 0-139 mo). In 43 patients (86%), balloon dilatation was technically successful. In the remaining 7 patients (14%), it was impossible to pass the strictured segment with the guidewire. In 20 of 43 patients (47%) having a technically successful procedure, the procedure was also clinically successful, with median follow-up after balloon dilatation of 35.5 months (range, 0-102 mo). We did not identify any patient or
- Published
- 2018
- Full Text
- View/download PDF
28. Short-term outcomes of laparoscopic versus open left lateral sectionectomy: an international propensity score matched study
- Author
-
Fichtinger, R., primary, van der Poel, M., additional, Gorcek, B., additional, Verhoef, C., additional, de Boer, M., additional, D'Hondt, M., additional, Abu Hilal, M., additional, Terkivatan, T., additional, van Dam, R., additional, and Besselink, M., additional
- Published
- 2018
- Full Text
- View/download PDF
29. Recommendations for the Management of Women with Suspected Hepatocellular Adenoma and Childbearing Potential
- Author
-
Gaspersz, M., primary, Klompenhouwer, A.J., additional, Broker, M., additional, Willemssen, F., additional, Tomeer, M., additional, Terkivatan, T., additional, de Man, R., additional, Ijzermans, J., additional, and van Vugt, J., additional
- Published
- 2018
- Full Text
- View/download PDF
30. Minimizing the number of urological complications after kidney transplant: A comparative study of two types of external ureteral stents
- Author
-
Ooms, L.S.S. (Liselotte), Spaans, L.G. (Laura G.), Betjes, M.G.H. (Michiel), IJzermans, J.N.M. (Jan), Terkivatan, T. (Türkan), Ooms, L.S.S. (Liselotte), Spaans, L.G. (Laura G.), Betjes, M.G.H. (Michiel), IJzermans, J.N.M. (Jan), and Terkivatan, T. (Türkan)
- Abstract
Objectives: The aim of this study was to evaluate the effects of 2 types of external ureteral stents on the number of urological complications after kidney transplant. Materials and Methods: Data were retrospectively collected from 366 consecutive transplants performed between January 2013 and January 2015 in our hospital, in which an external ureteral stent was placed during surgery and removed after 9 days. Urological complications were defined as urinary leakage or ureteral stenosis requiring percutaneous nephrostomy placement. Results: A total of 197 patients received a straight stent with 2 larger side holes (type A; 8F “Covidien” tube; Covidien, Dublin, Ireland) and 169 patients received a single J stent with 7 smaller side holes (type B; 7F “Teleflex” single J stent; Teleflex Medical, Athlone, Ireland). We found a significantly higher number of percutaneous nephrostomy placements with type A stents, with 34 (17%) versus 16 (9%) in type B (P =.030). Reason for percutaneous nephrostomy placement, occurrence of stent dysfunction, and need for early removal (< 8 days) were equal in both groups (P =.397), whereas incidence of rejection and urinary tract infection were higher in type B stent group. Patient and graft survival did not differ between the groups. Conclusions: Use of the type B stent was associated with less urological complications compared with the type A stent.
- Published
- 2017
- Full Text
- View/download PDF
31. PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma
- Author
-
Sideras, K. (Kostandinos), Biermann, K. (Katharina), Verheij, J. (Joanne), Takkenberg, B.R. (Bart R.), Mancham, S. (Shanta), Hansen, B.E. (Bettina), Schutz, H.M. (Hannah M.), Man, R.A. (Robert) de, Sprengers, D. (Dave), Buschow, S.I. (Sonja I.), Verseput, M.C.M. (Maddy C. M.), Boor, P.P.C. (Patrick), Pan, Q. (Qiuwei), Gulik, T.M. (Thomas) van, Terkivatan, T. (Türkan), IJzermans, J.N.M. (Jan), Beuers, U. (Ulrich), Sleijfer, S. (Stefan), Bruno, M.J. (Marco), Kwekkeboom, J. (Jaap), Sideras, K. (Kostandinos), Biermann, K. (Katharina), Verheij, J. (Joanne), Takkenberg, B.R. (Bart R.), Mancham, S. (Shanta), Hansen, B.E. (Bettina), Schutz, H.M. (Hannah M.), Man, R.A. (Robert) de, Sprengers, D. (Dave), Buschow, S.I. (Sonja I.), Verseput, M.C.M. (Maddy C. M.), Boor, P.P.C. (Patrick), Pan, Q. (Qiuwei), Gulik, T.M. (Thomas) van, Terkivatan, T. (Türkan), IJzermans, J.N.M. (Jan), Beuers, U. (Ulrich), Sleijfer, S. (Stefan), Bruno, M.J. (Marco), and Kwekkeboom, J. (Jaap)
- Abstract
Novel systemic treatments for hepatocellular carcinoma (HCC) are strongly needed. Immunotherapy is a promising strategy that can induce specific antitumor immune responses. Understanding the mechanisms of immune resistance by HCC is crucial for development of suitable immunotherapeutics. We used immunohistochemistry on tissue-microarrays to examine the co-expression of the immune inhibiting molecules PD-L1, Galectin-9, HVEM and IDO, as well as tumor CD8+ lymphocyte infiltration in HCC, in two independent cohorts of patients. We found that at least some expression in tumor cells was seen in 97% of cases for HVEM, 83% for PD-L1, 79% for Gal-9 and 66% for IDO. In the discovery cohort (n = 94), we found that lack of, or low, tumor expression of PD-L1 (p < 0.001), Galectin-9 (p < 0.001) and HVEM (p < 0.001), and low CD8+TIL count (p = 0.016), were associated with poor HCC-specific survival. PD-L1, Galectin-9 and CD8+TIL count were predictive of HCC-specific survival independent of baseline clinicopathologic characteristics and the combination of these markers was a powerful predictor of HCC-specific survival (HR 0.29; p <0.001). These results were confirmed in the validation cohort (n = 60). We show that low expression levels of PD-L1 and Gal-9 in combination with low CD8+TIL count predict extremely poor HCC-specific survival and it requires a change in two of these parameters to significantly improve prognosis. In conclusion, intra-tumoral expression of these immune inhibiting molecules was observed in the majority of HCC patients. Low expression of PD-L1 and Galectin-9 and low CD8+TIL count are associated with poor HCC-specific survival. Combining immune biomarkers leads to superior predictors of HCC mortality.
- Published
- 2017
- Full Text
- View/download PDF
32. Randomized clinical trial of open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery after surgery programme (ORANGE II study)
- Author
-
Wong-Lun-Hing, E M, primary, van Dam, R M, additional, van Breukelen, G J P, additional, Tanis, P J, additional, Ratti, F, additional, van Hillegersberg, R, additional, Slooter, G D, additional, de Wilt, J H W, additional, Liem, M S L, additional, de Boer, M T, additional, Klaase, J M, additional, Neumann, U P, additional, Aldrighetti, L A, additional, Dejong, C H C, additional, Terkivatan, T, additional, Verhoef, C, additional, Porte, R J, additional, Haverman, J W, additional, Busch, O R, additional, Boermeester, M A, additional, Besselink, M G, additional, Molenaar, I Q, additional, Borel Rinkes, I H M, additional, Bosscha, K, additional, van der Vorst, J R, additional, de Waard, J W D, additional, Gerhards, M F, additional, Patijn, G A, additional, Schmeding, M, additional, Primrose, J N, additional, Abu Hilal, M, additional, Dagher, I, additional, Laurent, A, additional, Topal, B, additional, Edwin, B, additional, Lassen, K, additional, van Duyn, E B, additional, Ambergen, A W, additional, Olde Damink, S W, additional, and Bemelmans, M H, additional
- Published
- 2017
- Full Text
- View/download PDF
33. Hepatocellular adenoma: When and how to treat? Update of current evidence
- Author
-
Thomeer, M.G.J. (Maarten), Bröker, M.E.E. (Mirelle), Verheij, J. (Joanne), Doukas, M. (Michael), Terkivatan, T. (Türkan), Bijdevaate, D.C. (Diederik), Man, R.A. (Robert) de, Moelker, A. (Adriaan), IJzermans, J.N.M. (Jan), Thomeer, M.G.J. (Maarten), Bröker, M.E.E. (Mirelle), Verheij, J. (Joanne), Doukas, M. (Michael), Terkivatan, T. (Türkan), Bijdevaate, D.C. (Diederik), Man, R.A. (Robert) de, Moelker, A. (Adriaan), and IJzermans, J.N.M. (Jan)
- Abstract
Hepatocellular adenoma (HCA) is a rare, benign liver tumor. Discovery of this tumor is usually as an incidental finding, correlated with the use of oral contraceptives, or pregnancy. Treatment options have focused on conservative management for the straightforward, smaller lesions (<5 cm), with resection preferred for larger lesions (>5 cm) that pose a greater risk of hemorrhage or malignant progression. In recent years, a new molecular subclassification of HCA has been proposed, associated with characteristic morphological features and loss or increased expression of immunohistochemical markers. This subclassification could possibly provide considerable benefits in terms of patient stratification, and the selection of treatment options. In this review we discuss the decision-making processes and associated risk analyses that should be made based on lesion size, and subtype. The usefulness of this subclassification system in terms of the procedures instigated as part of the diagnostic work-up of a suspected HCA will be outlined, and suitable treatment schemes proposed.
- Published
- 2016
- Full Text
- View/download PDF
34. Vascular multiplicity should not be a contra-Indication for live kidney donation and transplantation
- Author
-
Lafranca, J.A. (Jeffrey), Bruggen, M.V. (Mark Van), Kimenai, H.J.A.N. (Hendrikus), Tran, T.C.K. (Thi C. K.), Terkivatan, T. (Türkan), Betjes, M.G.H. (Michiel), Jzermans, J.N.M.I. (Jan N. M.I.), Dor, F.J.M.F. (Frank), Lafranca, J.A. (Jeffrey), Bruggen, M.V. (Mark Van), Kimenai, H.J.A.N. (Hendrikus), Tran, T.C.K. (Thi C. K.), Terkivatan, T. (Türkan), Betjes, M.G.H. (Michiel), Jzermans, J.N.M.I. (Jan N. M.I.), and Dor, F.J.M.F. (Frank)
- Abstract
Background: Whether vascular multiplicity should be considered as contraindication and therefore 'extended donor criterion' is still under debate. Methods: Data from all live kidney donors from 2006-2013 (n=951) was retrospectively reviewed. Vascular anatomy as imaged by MRA, CTA or other modalities was compared with intraoperative findings. Furthermore, the influence of vascular multiplicity on outcome of donors and recipients was studied. Results: In 237 out of 951 donors (25%), vascular multiplicity was present. CTA had the highest accuracy levels regarding vascular anatomy assessment. Regarding outcome of donors with vascular multiplicity
- Published
- 2016
- Full Text
- View/download PDF
35. Robotic surgery rapidly and successfully implemented in a high volume laparoscopic center on living kidney donation
- Author
-
Janki, S., primary, Klop, K. W. J., additional, Hagen, S. M., additional, Terkivatan, T., additional, Betjes, M. G. H., additional, Tran, T. C. K., additional, and Ijzermans, J. N. M., additional
- Published
- 2016
- Full Text
- View/download PDF
36. Open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery ERAS® programme (ORANGE II-trial): study protocol for a randomised controlled trial
- Author
-
Van Dam, Ronald M., Wong-Lun-Hing, Edgar M., Van Breukelen, Gerard J. P., Stoot, Jan H. M. B., Van Der Vorst, Joost R., Bemelmans, Marc H. A., Olde Damink, Steven W. M., Lassen, Kristoffer, Dejong, Cornelis H. C., ORANGE II Study Group, Busch, O. R., Tanis, P. J., Hoekstra, L. T., Van Hillegersberg, R., Molenaar, I. Q., Verhoef, C., Terkivatan, T., De Jonge, J., Slooter, G. D., Roumen, R. M., Klaase, J. M., Van Duyn, E. B., Boscha, K., Porte, R. J., De Boer, M. T., Haveman, J. W., De Wilt, J. H., Buyne, O. R., Van Duijvendijk, P., Neumann, U., Schmeding, M., Ferla, G., Aldrighetti, L. A., Ferla, F., Primrose, J. N., Abu Hilal, M., Pearce, N. W., Dagher, I., Laurent, A., Topal, B., Troisi, R. I., Edwin, B., Boermeester, M. A., Borel Rinkes, I. H., Ambergen, A. W., AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, CCA -Cancer Center Amsterdam, Surgery, AII - Amsterdam institute for Infection and Immunity, RS: CAPHRI School for Public Health and Primary Care, RS: NUTRIM - R2 - Gut-liver homeostasis, RS: FPN M&S I, FHML Methodologie & Statistiek, Dean and Directors Office, van Dam Ronald, M., Wong-Lun-Hing Edgar, M., Van Breukelen Gerard, J. P., Stoot Jan, H. M. B., van der Vorst Joost, R., Bemelmans Marc, H. A., Damink Steven W. M., Olde, Lassen, Kristoffer, Dejong Cornelis, H. C., and Aldrighetti, L
- Subjects
Laparoscopic surgery ,Time Factors ,EARLY AMBULATION ,medicine.medical_treatment ,Medicine (miscellaneous) ,law.invention ,Study Protocol ,Quality of life ,Randomized controlled trial ,QUALITY-OF-LIFE ,law ,Left lateral sectionectomy ,Clinical endpoint ,Outpatient clinic ,INCISIONAL HERNIA ,Pharmacology (medical) ,Prospective Studies ,Registries ,ERAS ,Hospital Costs ,Prospective cohort study ,lcsh:R5-920 ,PARTIAL-HEPATECTOMY ,Hernia, Abdominal ,INTESTINAL RESECTION ,Europe ,Treatment Outcome ,COLONIC RESECTION ,Patient Satisfaction ,Research Design ,Evaluation of complex medical interventions Tissue engineering and pathology [NCEBP 2] ,lcsh:Medicine (General) ,CLINICAL-TRIALS ,RCT ,medicine.medical_specialty ,CONTROLLED REHABILITATION ,Quality of Care [ONCOL 4] ,Cicatrix ,Double-Blind Method ,Body Image ,medicine ,Humans ,Hepatectomy ,Hernia ,Open liver resection ,business.industry ,Recovery of Function ,Length of Stay ,medicine.disease ,Surgery ,COLORECTAL LIVER METASTASES ,Clinical trial ,NUMERIC RATING-SCALE ,Quality of Life ,Laparoscopy ,business - Abstract
Trials 13, 54 (2012). doi:10.1186/1745-6215-13-54, Published by BioMed Central, London
- Published
- 2012
37. Randomized controlled trial comparing hand-assisted retroperitoneoscopic versus standard laparoscopic donor nephrectomy
- Author
-
Dols, L.F., Kok, N.F., D'Ancona, F.C.H., Klop, K.W., Tran, T.C.K., Langenhuijsen, J.F., Terkivatan, T., Dor, F.J., Weimar, W., Dooper, I., Ijzermans, J.N.M., Dols, L.F., Kok, N.F., D'Ancona, F.C.H., Klop, K.W., Tran, T.C.K., Langenhuijsen, J.F., Terkivatan, T., Dor, F.J., Weimar, W., Dooper, I., and Ijzermans, J.N.M.
- Abstract
Contains fulltext : 136652.pdf (publisher's version ) (Closed access), BACKGROUND: Laparoscopic donor nephrectomy (LDN) has become the gold standard for live-donor nephrectomy, as it results in a short convalescence time and increased quality of life. However, intraoperative safety has been debated, as severe complications occur incidentally. Hand-assisted retroperitoneoscopic donor nephrectomy (HARP) is an alternative approach, combining the safety of hand-guided surgery with the benefits of endoscopic techniques and retroperitoneal access. We assessed the best approach to optimize donors' quality of life and safety. METHODS: In two tertiary referral centers, donors undergoing left-sided nephrectomy were randomly assigned to HARP or LDN. Primary endpoint was physical function, one of the dimensions of the Short Form-36 questionnaire on quality of life, at 1 month postoperatively. Secondary endpoints included intraoperative events and operation times. Follow-up was 1 year. RESULTS: In total, 190 donors were randomized. Physical function at 1 month follow-up did not significantly differ between groups (estimated difference, 1.79; 95% confidence interval, -4.1 to 7.68; P=0.55). HARP resulted in significantly shorter skin-to-skin time (mean, 159 vs. 188 min; P<0.001), shorter warm ischemia time (2 vs. 5 min; P<0.001) and a lower intraoperative event rate (5% vs. 11%, P=0.117). Length of stay (both 3 days; P=0.135) and postoperative complication rate (8% vs. 8%; P=1.00) were not significantly different. Potential graft-related complications did not significantly differ (6% vs. 13%; P=0.137). CONCLUSIONS: Compared with LDN, left-sided HARP leads to similar quality of life, shorter operating time, and warm ischemia time. Therefore, we recommend HARP as a valuable alternative to the laparoscopic approach for left-sided donor nephrectomy.
- Published
- 2014
38. Independent risk factors for urological complications after deceased donor kidney transplantation
- Author
-
Slagt, I.K.B. (Inez), IJzermans, J.N.M. (Jan), Visser, L.J. (Laurents), Weimar, W. (Willem), Roodnat, J.I. (Joke), Terkivatan, T. (Türkan), Slagt, I.K.B. (Inez), IJzermans, J.N.M. (Jan), Visser, L.J. (Laurents), Weimar, W. (Willem), Roodnat, J.I. (Joke), and Terkivatan, T. (Türkan)
- Abstract
Urological complications after kidney transplantation are mostly related to the ureteroneocystostomy, often requiring interventions with additional costs, morbidity and mortality. Our aim was to assess risk factors for urological complications in deceased donor kidney transplantation. Between January 2000 and December 2011, 566 kidney transplantations were performed with deceased donor kidneys. Recipients were divided in a group with, and a group without urological complications, defined as the need for a percutaneous nephrostomy catheter or surgical revision of the ureteroneocystostomy. Univariate and multivariate analyses were performed. Univariate analysis showed increased number of male donors (p = 0.041), male recipients (p = 0.002), pre-emptively transplanted recipients (p = 0.007), and arterial reconstructions (p = 0.004) in the group with urological complications. Less urological complications occurred in recipients on hemodialysis (p = 0.005). More overall surgical interventions (p<0.001), surgical site infections (p = 0.042), urinary tract infections (p<0.001) and lymphoceles (p<0.001) occurred in the group with urological complications. Multivariate analysis showed that male recipients (p = 0.010) and arterial reconstructions (p = 0.019) were independent risk factors. No difference was found between both groups in patient or graft survival. In conclusion, recipient male gender and arterial reconstruction are independent risk factors for urological complications after deceased donor kidney transplantation. Nevertheless, graft and recipient survival is not different between both groups.
- Published
- 2014
- Full Text
- View/download PDF
39. Is current perioperative practice in hepatic surgery based on enhanced recovery after surgery (ERAS) principles?
- Author
-
Wong-Lun-Hing, E.M., Dam, R.M. van, Heijnen, L.A., Busch, O.R., Terkivatan, T., Hillegersberg, R. van, Slooter, G.D., Klaase, J., Wilt, J.H.W. de, Bosscha, K., Neumann, U.P., Topal, B., Aldrighetti, L.A., Dejong, C.H., Wong-Lun-Hing, E.M., Dam, R.M. van, Heijnen, L.A., Busch, O.R., Terkivatan, T., Hillegersberg, R. van, Slooter, G.D., Klaase, J., Wilt, J.H.W. de, Bosscha, K., Neumann, U.P., Topal, B., Aldrighetti, L.A., and Dejong, C.H.
- Abstract
Contains fulltext : 138363.pdf (publisher's version ) (Closed access), BACKGROUND: The worldwide introduction of multimodal enhanced recovery programs has also changed perioperative care in patients who undergo liver resection. This study was performed to assess current perioperative practice in liver surgery in 11 European HPB centers and compare it to enhanced recovery after surgery (ERAS) principles. METHODS: In each unit, 15 consecutive patients (N = 165) who underwent hepatectomy between 2010 and 2012 were retrospectively analyzed. Compliance was classified as "full," "partial," or "poor" whenever >/= 80, >/= 50, or <50 % of the 22 ERAS protocol core items were met. The primary study end point was overall compliance with the ERAS core program per unit and per perioperative phase. RESULTS: Most patients were operated on for malignancy (91 %) and 56 % were minor hepatectomies. The median number of implemented ERAS core items was 9 (range = 7-12) across all centers. Compliance was partial in the preoperative (median 2 of 3 items, range = 1-3) and perioperative phases (median 5 of 10 items, range: 4-7). Median postoperative compliance was poor (median 2 of 9 items, range = 0-4). A statistically significant difference was observed between median length of stay and median time to recovery (7 vs. 5 days, P < 0.001). CONCLUSION: Perioperative care among centers that perform liver resections varied substantially. In current HPB surgical practice, some elements of the ERAS program, e.g., preoperative counselling and minimal fasting, have already been implemented. Elements in the perioperative phase (avoidance of drains and nasogastric tube) and postoperative phase (early resumption of oral intake, early mobilization, and use of recovery criteria) should be further optimized.
- Published
- 2014
40. Robotic surgery rapidly and successfully implemented in a high volume laparoscopic center on living kidney donation.
- Author
-
Janki, S., Klop, K. W. J., Hagen, S. M., Terkivatan, T., Betjes, M. G. H., Tran, T. C. K., and Ijzermans, J. N. M.
- Published
- 2017
- Full Text
- View/download PDF
41. Is Current Perioperative Practice in Hepatic Surgery Based on Enhanced Recovery After Surgery (ERAS) Principles?
- Author
-
Wong-Lun-Hing, E. M., primary, van Dam, R. M., additional, Heijnen, L. A., additional, Busch, O. R. C., additional, Terkivatan, T., additional, van Hillegersberg, R., additional, Slooter, G. D., additional, Klaase, J., additional, de Wilt, J. H. W., additional, Bosscha, K., additional, Neumann, U. P., additional, Topal, B., additional, Aldrighetti, L. A., additional, and Dejong, C. H. C., additional
- Published
- 2013
- Full Text
- View/download PDF
42. Pregnancy and liver adenoma management: PALM-study
- Author
-
Aalten, S.M. (Susanna) van, Bröker, M.E.E. (Mirelle), Busschbach, J.J. (Jan) van, Koning, H.J. (Harry) de, Man, R.A. (Robert) de, Steegers, E.A.P. (Eric), Steyerberg, E.W. (Ewout), Terkivatan, T. (Türkan), IJzermans, J.N.M. (Jan), Aalten, S.M. (Susanna) van, Bröker, M.E.E. (Mirelle), Busschbach, J.J. (Jan) van, Koning, H.J. (Harry) de, Man, R.A. (Robert) de, Steegers, E.A.P. (Eric), Steyerberg, E.W. (Ewout), Terkivatan, T. (Türkan), and IJzermans, J.N.M. (Jan)
- Abstract
__Background:__ Hepatocellular adenoma (HCA) in pregnant women requires special considerations because of the risk of hormone induced growth and spontaneous rupture, which may threaten the life of both mother and child. Due to scarcity of cases there is no evidence-based algorithm for the evaluation and management of HCA during pregnancy. Most experts advocate that women with HCA should not get pregnant or advise surgical resection before pregnancy. Whether it is justified to deny a young woman a pregnancy, as the biological behavior may be less threatening than presumed depends on the incidence of HCA growth and the subsequent clinical events during pregnancy. We aim to investigate the management and outcome of HCA during pregnancy and labor based on a prospectively acquired online database in the Netherlands. __Methods/design:__ The Pregnancy And Liver adenoma Management (PALM) - study is a multicentre prospective study in three cohorts of pregnant patients. In total 50 pregnant patients, ≥ 18 years of age with a radiologically and/or histologically proven diagnosis of HCA will be included in the study. Radiological diagnosis of HCA will be based on contrast enhanced MRI. Lesions at inclusion must not exceed 5 cm. The study group will be compared to a healthy control group of 63 pregnant patients and a group of 63 pregnant patients with diabetes mellitus without HCA. During their pregnancy HCA patients will be closely monitored by means of repetitive ultrasound (US) at 14, 20, 26, 32 and 38 weeks of gestation and 6 and 12 weeks postpartum. Both control groups will undergo US of the liver at 14 weeks of gestation to exclude HCA lesions in the liver. All groups will be asked to fill out quality of life related questionnaires. __Discussion:__ The study will obtain information about the behaviour of HCA during pregnancy, the clinical consequences for mother and child and the impact of having a HCA during pregnancy on the health related quality of life of these young w
- Published
- 2012
- Full Text
- View/download PDF
43. Open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery ERAS(R) programme (ORANGE II-trial): study protocol for a randomised controlled trial
- Author
-
van Dam, R.M., Wong-Lun-Hing, E.M., Breukelen, G.J van, Stoot, J.H., van der Vorst, J.R., Bemelmans, M.H.A., Olde Damink, S.W., Lassen, K., Dejong, C.H., Busch, O.R., Tanis, P.J., Hoekstra, L.T., Hillegersberg, R. van, Verhoef, C., Terkivatan, T., Jonge, J de, Slooter, G.D., Roumen, R.M., Klaase, J.M., Duyn, E.B. van, Boscha, K., Porte, R.J., Boer, M.T. De, Haveman, J.W., Wilt, J.H. de, Buyne, O.R., Duijvendijk, P. van, Neumann, U., Schmeding, M., et al., van Dam, R.M., Wong-Lun-Hing, E.M., Breukelen, G.J van, Stoot, J.H., van der Vorst, J.R., Bemelmans, M.H.A., Olde Damink, S.W., Lassen, K., Dejong, C.H., Busch, O.R., Tanis, P.J., Hoekstra, L.T., Hillegersberg, R. van, Verhoef, C., Terkivatan, T., Jonge, J de, Slooter, G.D., Roumen, R.M., Klaase, J.M., Duyn, E.B. van, Boscha, K., Porte, R.J., Boer, M.T. De, Haveman, J.W., Wilt, J.H. de, Buyne, O.R., Duijvendijk, P. van, Neumann, U., Schmeding, M., and et al.
- Abstract
Contains fulltext : 108907.pdf (publisher's version ) (Open Access), BACKGROUND: The use of lLaparoscopic liver resection in terms of time to functional recovery, length of hospital stay (LOS), long-term abdominal wall hernias, costs and quality of life (QOL) has never been studied in a randomised controlled trial. Therefore, this is the subject of the international multicentre randomised controlled ORANGE II trial. METHODS: Patients eligible for left lateral sectionectomy (LLS) of the liver will be recruited and randomised at the outpatient clinic. All randomised patients will undergo surgery in the setting of an ERAS programme. The experimental design produces two randomised arms (open and laparoscopic LLS) and a prospective registry. The prospective registry will be based on patients that cannot be randomised because of the explicit treatment preference of the patient or surgeon, or because of ineligibility (not meeting the in- and exclusion criteria) for randomisation in this trial. Therefore, all non-randomised patients undergoing LLS will be approached to participate in the prospective registry, thereby allowing acquisition of an uninterrupted prospective series of patients. The primary endpoint of the ORANGE II trial is time to functional recovery. Secondary endpoints are postoperative LOS, percentage readmission, (liver-specific) morbidity, QOL, body image and cosmetic result, hospital and societal costs over 1 year, and long-term incidence of incisional hernias. It will be assumed that in patients undergoing laparoscopic LLS, length of hospital stay can be reduced by two days. A sample size of 55 patients in each randomisation arm has been calculated to detect a 2-day reduction in LOS (90% power and alpha = 0.05 (two-tailed)).The ORANGE II trial is a multicenter randomised controlled trial that will provide evidence on the merits of laparoscopic surgery in patients undergoing LLS within an enhanced recovery ERAS programme. TRIAL REGISTRATION: ClinicalTrials.gov NCT00874224.
- Published
- 2012
44. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis
- Author
-
van Buuren, Henk, van Hoogstraten, HJF (Hubert), Terkivatan, T, Schalm, Solko, Vleggaar, FP, and Internal Medicine
- Subjects
SDG 3 - Good Health and Well-being - Published
- 2000
45. Management of hepatocellular adenoma during pregnancy
- Author
-
Noels, J.E. (Johanna), Aalten, S.M. (Susanna) van, Windt, D.J. (Dirk) van der, Kok, N.F.M. (Niels), Man, R.A. (Robert) de, Terkivatan, T. (Türkan), IJzermans, J.N.M. (Jan), Noels, J.E. (Johanna), Aalten, S.M. (Susanna) van, Windt, D.J. (Dirk) van der, Kok, N.F.M. (Niels), Man, R.A. (Robert) de, Terkivatan, T. (Türkan), and IJzermans, J.N.M. (Jan)
- Abstract
Background & Aims: Hepatocellular adenoma in pregnant women requires special considerations because of the risk of hormone induced growth and rupture. To prevent these potential lethal complications, pregnancy is either often discouraged or the surgical resection of large adenomas is recommended. It may be questioned whether it is justified to deny a young woman a pregnancy, as the biological behaviour of hepatocellular adenoma may be less threatening than presumed. In this study we establish the management of hepatocellular adenoma during pregnancy based on our own experience and literature. Methods: Twelve women with documented hepatocellular adenoma were closely monitored during a total of 17 pregnancies between 2000 and 2009. Their files were reviewed. Results: In four cases, hepatocellular adenomas grew during pregnancy, requiring a Caesarean section in one patient (two pregnancies) at 36 and 34 weeks because of an assumed high risk of rupture. In one case radiofrequency ablation therapy was applied in the first trimester to treat a hormone sensitive hepatocellular adenoma, thereby excluding potential growth later in pregnancy. No intervention was performed in the other 14 cases and all pregnancies had an uneventful course with a successful maternal and fetal outcome. Conclusions: A "wait and see" management may be advocated in pregnant women presenting with a hepatocellular adenoma. In women with large tumours or in whom hepatocellular adenoma had complicated previous pregnancies, surgical resection may be recommended. In women with smaller adenomas it may no longer be necessary to discourage pregnancy.
- Published
- 2011
- Full Text
- View/download PDF
46. Hand-assisted retroperitoneoscopic versus standard laparoscopic donor nephrectomy: HARP-trial
- Author
-
Dols, L.F.C. (Leonienke), Kok, N.F.M. (Niels), Terkivatan, T. (Türkan), Tran, T.C.K. (Khe), D'Ancona, F.C. (Frank), Langenhuijsen, J.F. (Johan), Mertens Zur Borg, I.R.A.M. (Ingrid), Alwayn, I.P.J. (Ian), Hendriks, M.P. (Mark), Dooper, I.M. (Ine), Weimar, W. (Willem), IJzermans, J.N.M. (Jan), Dols, L.F.C. (Leonienke), Kok, N.F.M. (Niels), Terkivatan, T. (Türkan), Tran, T.C.K. (Khe), D'Ancona, F.C. (Frank), Langenhuijsen, J.F. (Johan), Mertens Zur Borg, I.R.A.M. (Ingrid), Alwayn, I.P.J. (Ian), Hendriks, M.P. (Mark), Dooper, I.M. (Ine), Weimar, W. (Willem), and IJzermans, J.N.M. (Jan)
- Abstract
Background. Transplantation is the only treatment offering long-term benefit to patients with chronic kidney failure. Live donor nephrectomy is performed on healthy individuals who do not receive direct therapeutic benefit of the procedure themselves. In order to guarantee the donor's safety, it is important to optimise the surgical approach. Recently we demonstrated the benefit of laparoscopic nephrectomy experienced by the donor. However, this method is characterised by higher in hospital costs, longer operating times and it requires a well-trained surgeon. The hand-assisted retroperitoneoscopic technique may be an alternative to a complete laparoscopic, transperitoneal approach. The peritoneum remains intact and the risk of visceral injuries is reduced. Hand-assistance results in a faster procedure and a significantly reduced operating time. The feasibility of this method has been demonstrated recently, but as to date there are no data available advocating the use of one technique above the other. Methods/design. The HARP-trial is a multi-centre randomised controlled, single-blind trial. The study compares the hand-assisted retroperitoneoscopic approach with standard laparoscopic donor nephrectomy. The objective is to determine the best approach for live donor nephrectomy to optimise donor's safety and comfort while reducing donation related costs. Discussion. This study will contribute to the evidence on any benefits of hand-assisted retroperitoneoscopic versus standard laparoscopic donor nephrectomy. Trial Registration. Dutch Trial Register NTR1433.
- Published
- 2010
- Full Text
- View/download PDF
47. Diagnosis and treatment of hepatocellular adenoma in the Netherlands: Similarities and differences
- Author
-
Aalten, S.M. (Susanna) van, Terkivatan, T. (Türkan), Man, R.A. (Robert) de, Windt, D.J. (Dirk) van der, Kok, N.F.M. (Niels), Dwarkasing, R.S. (Roy), IJzermans, J.N.M. (Jan), Aalten, S.M. (Susanna) van, Terkivatan, T. (Türkan), Man, R.A. (Robert) de, Windt, D.J. (Dirk) van der, Kok, N.F.M. (Niels), Dwarkasing, R.S. (Roy), and IJzermans, J.N.M. (Jan)
- Abstract
Background: The diagnosis of hepatocellular adenoma (HA) has a great impact on the lives of young women and may pose clinical dilemmas to the clinician since there are no standardized protocols to follow. We aimed to establish expert opinions on diagnosis and treatment of HA by collecting data from a nationwide questionnaire in the Netherlands. Methods: A questionnaire was sent to 20 Dutch hospitals known to offer hepatologic and surgical experience on liver tumours. Results: 17 hospitals (85%) responded to the questionnaire. Annually, a median of 52 patients presented with a solid liver tumour. In 15 (88%) hospitals, hepatic adenomas were diagnosed with contrast-enhanced, multiphase spiral CT or MRI. In 2 (12%) hospitals, histology was required as part of a management protocol. Surveillance after withdrawal of oral contraceptives was the initial policy in all clinics. MRI, CT or ultrasound was used for follow-up. Criteria for surgical resection were a tumour size >5 cm and abdominal complaints. In 5 (29%) hospitals, patients were dismissed from follow-up after surgery. In complex cases (e.g. large, multiple or centrally localized lesions, a wish for pregnancy), the trea
- Published
- 2010
- Full Text
- View/download PDF
48. Hand-assisted retroperitoneoscopic versus standard laparoscopic donor nephrectomy: HARP-trial.
- Author
-
Dols, L.F., Kok, N.F., Terkivatan, T., Tran, T.C.K., D'Ancona, F.C.H., Langenhuijsen, J.F., Borg, I.R. zur, Alwayn, I.P., Hendriks, M.P., Dooper, P.M.M., Weimar, W., Ijzermans, J.N.M., Dols, L.F., Kok, N.F., Terkivatan, T., Tran, T.C.K., D'Ancona, F.C.H., Langenhuijsen, J.F., Borg, I.R. zur, Alwayn, I.P., Hendriks, M.P., Dooper, P.M.M., Weimar, W., and Ijzermans, J.N.M.
- Abstract
Contains fulltext : 88436.pdf (publisher's version ) (Open Access), BACKGROUND: Transplantation is the only treatment offering long-term benefit to patients with chronic kidney failure. Live donor nephrectomy is performed on healthy individuals who do not receive direct therapeutic benefit of the procedure themselves. In order to guarantee the donor's safety, it is important to optimise the surgical approach. Recently we demonstrated the benefit of laparoscopic nephrectomy experienced by the donor. However, this method is characterised by higher in hospital costs, longer operating times and it requires a well-trained surgeon. The hand-assisted retroperitoneoscopic technique may be an alternative to a complete laparoscopic, transperitoneal approach. The peritoneum remains intact and the risk of visceral injuries is reduced. Hand-assistance results in a faster procedure and a significantly reduced operating time. The feasibility of this method has been demonstrated recently, but as to date there are no data available advocating the use of one technique above the other. METHODS/DESIGN: The HARP-trial is a multi-centre randomised controlled, single-blind trial. The study compares the hand-assisted retroperitoneoscopic approach with standard laparoscopic donor nephrectomy. The objective is to determine the best approach for live donor nephrectomy to optimise donor's safety and comfort while reducing donation related costs. DISCUSSION: This study will contribute to the evidence on any benefits of hand-assisted retroperitoneoscopic versus standard laparoscopic donor nephrectomy. TRIAL REGISTRATION: Dutch Trial Register NTR1433.
- Published
- 2010
49. Abdominal wall paresis as a complication of laparoscopic surgery
- Author
-
Ramshorst, G.H. (Gabrielle) van, Kleinrensink, G.J. (Gert Jan), Hermans, J.J. (John), Terkivatan, T. (Türkan), Lange, J.F. (Johan), Ramshorst, G.H. (Gabrielle) van, Kleinrensink, G.J. (Gert Jan), Hermans, J.J. (John), Terkivatan, T. (Türkan), and Lange, J.F. (Johan)
- Abstract
Purpose: Abdominal wall nerve injury as a result of trocar placement for laparoscopic surgery is rare. We intend to discuss causes of abdominal wall paresis as well as relevant anatomy. Methods: A review of the nerve supply of the abdominal wall is illustrated with a rare case of a patient presenting with paresis of the internal oblique muscle due to a trocar lesion of the right iliohypogastric nerve after laparoscopic appendectomy. Results: Trocar placement in the upper lateral abdomen can damage the subcostal nerve (Th12), caudal intercostal nerves (Th7-11) and ventral rami of the thoracic nerves (Th7-12). Trocar placement in the lower abdomen can damage the ilioinguinal (L1 or L2) and iliohypogastric nerves (Th12-L1). Pareses of abdominal muscles due to trocar placement are rare due to overlap in innervation and relatively small sizes of trocar incisions. Conclusion: Knowledge of the anatomy of the abdominal wall is mandatory in order to avoid the injury of important structures during trocar placement.
- Published
- 2009
- Full Text
- View/download PDF
50. Intravesical Versus Extravesical Ureteroneocystostomy in Kidney Transplantation: A Systematic Review and Meta-Analysis
- Author
-
Slagt, I. K.B., primary, Klop, K. W.J., additional, IJzermans, J. N.M., additional, and Terkivatan, T., additional
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.